Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
Primary Purpose
Acute Spinal Cord Injury, Spinal Cord Injuries
Status
Recruiting
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Near Infra-Red Spectroscopy (NIRS) Sensor
Sponsored by
About this trial
This is an interventional device feasibility trial for Acute Spinal Cord Injury
Eligibility Criteria
Inclusion Criteria:
- Male or female aged 17 years or older
- Spinal injury between bony levels C3 and L1 inclusive
- Motor complete acute traumatic SCI (AIS A or B) or motor incomplete SCI (AIS C) with a total lower extremity motor score of less than 5
- Blunt (non-penetrating) SCI requiring posterior laminectomy with stabilization/fusion surgery within 72 hours of injury
- Able to communicate in English and provide informed consent
Exclusion Criteria:
- Isolated radiculopathy or cauda equina injury
- Spinal cord impairment secondary to tumour, infection, epidural bleeding, or ischemia (in
- Any condition or injury (e.g. Morel-Lavellee lesion) that would interfere with the application or readings of the NIRS sensor
- Associated traumatic condition that would interfere with the informed consent process or outcome assessments (e.g. traumatic brain injury, pelvic, abdominal, or thoracic injuries)
- Any other medical condition that, in the investigator's opinion, would render the protocol procedures dangerous
- Female patients who are pregnant
Sites / Locations
- Vancouver General HospitalRecruiting
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Arm 1
Arm Description
NIRS monitoring of spinal cord oxygenation and hemodynamics
Outcomes
Primary Outcome Measures
Feasibility Assessment - Overall
Study specific questionnaire will collected data on the the ease of sensor application, NIRS monitoring and sensor removal is recorded with this form. Series of questions requiring the assessment of the NIRS system using yes/no and 10-point scoring scale
Feasibility Assessment: Sensor Application
Study specific form will be used record data associated with application of the NIRS sensor, such as the laminectomy and instrumentation data, location of the sensor and ease of application (score out of 10).
Feasibility Assessment: Sensor Removal
Study specific form will be used to record the condition of the sensor and participants' experience (score out of 10) at the time of sensor removal
Secondary Outcome Measures
Full Information
NCT ID
NCT04811235
First Posted
March 15, 2021
Last Updated
June 30, 2023
Sponsor
University of British Columbia
Collaborators
United States Department of Defense
1. Study Identification
Unique Protocol Identification Number
NCT04811235
Brief Title
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
Official Title
"OMNI-SCI" Trial - "Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury" Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 24, 2022 (Actual)
Primary Completion Date
June 2, 2024 (Anticipated)
Study Completion Date
September 30, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of British Columbia
Collaborators
United States Department of Defense
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
The study involves the 'first-in-human' evaluation of a novel optical sensor which uses near-infrared spectroscopy (NIRS) technology to assess oxygenation and hemodynamics of the injured spinal cord. The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time. Our testing of this novel NIRS sensor in patients with acute SCI represents the first step in translating this technology for human use.
Detailed Description
This single-center, prospective observational study will enroll 10 patients admitted to Vancouver General Hospital (VGH) for treatment of an acute traumatic spine injury.
Promising preclinical data demonstrates that the oxygenation and hemodynamic measures of our Near Infra-Red Spectroscopy (NIRS) system closely match the invasive intraparenchymal measures obtained within the injured spinal cord. Further, the NIRS sensor is responsive and reflective of systemic hemodynamic changes. This clinical protocol represents the first application of this novel NIRS sensor in human SCI. Following operative decompression of the spinal cord via a posterior approach, the NIRS sensor will be placed over the dura for 7 days to monitor spinal cord oxygenation and tissue hemodynamics. Patients will be followed for 6 months and data collection for safety, feasibly and efficacy of the NIRS System.
The specific aims of this project are to:
Establish the safety, feasibility, and efficacy of our NIRS system in monitoring tissue oxygenation and hemodynamics of the injured spinal cord in human participants.
Complete the technical refinement of the NIRS system utilizing an iterative process guided by participant recruitment and data accrual during the trial.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Spinal Cord Injury, Spinal Cord Injuries
7. Study Design
Primary Purpose
Device Feasibility
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
10 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Arm 1
Arm Type
Experimental
Arm Description
NIRS monitoring of spinal cord oxygenation and hemodynamics
Intervention Type
Device
Intervention Name(s)
Near Infra-Red Spectroscopy (NIRS) Sensor
Intervention Description
The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time.
Primary Outcome Measure Information:
Title
Feasibility Assessment - Overall
Description
Study specific questionnaire will collected data on the the ease of sensor application, NIRS monitoring and sensor removal is recorded with this form. Series of questions requiring the assessment of the NIRS system using yes/no and 10-point scoring scale
Time Frame
Day 7
Title
Feasibility Assessment: Sensor Application
Description
Study specific form will be used record data associated with application of the NIRS sensor, such as the laminectomy and instrumentation data, location of the sensor and ease of application (score out of 10).
Time Frame
Day 1
Title
Feasibility Assessment: Sensor Removal
Description
Study specific form will be used to record the condition of the sensor and participants' experience (score out of 10) at the time of sensor removal
Time Frame
Day 7
Other Pre-specified Outcome Measures:
Title
Safety Assessment - Neurologic Function
Description
Neurologic function will be assessed using the International Standards for Neurologic Classification of Spinal Cord Injury (ISNCSCI) to determine if the application, 7-day placement, or removal of the NIRS sensor is associated with any deterioration in spinal cord function.
Time Frame
6 Month
Title
Safety Assessment - Wound Assessment
Description
The externalization of a foreign body may lead to an increased risk of surgical site infection. Any incidence of wound infection will be monitored and document on a wound assessment form.
Time Frame
Day 7
Title
Safety Assessment - Adverse Events
Description
The incidence of AEs in the acute SCI patient population is significant. For the purposes of this study, and in keeping with standard of care on the Acute Spine Unit at study site, all AEs will be recorded utilizing the Spine Adverse Event (SAVES) form, a well-established system for prospectively documenting AEs in spine patients
Time Frame
6 Months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
17 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male or female aged 17 years or older
Spinal injury between bony levels C3 and L1 inclusive
Motor complete acute traumatic SCI (AIS A or B) or motor incomplete SCI (AIS C) with a total lower extremity motor score of less than 5
Blunt (non-penetrating) SCI requiring posterior laminectomy with stabilization/fusion surgery within 72 hours of injury
Able to communicate in English and provide informed consent
Exclusion Criteria:
Isolated radiculopathy or cauda equina injury
Spinal cord impairment secondary to tumour, infection, epidural bleeding, or ischemia (in
Any condition or injury (e.g. Morel-Lavellee lesion) that would interfere with the application or readings of the NIRS sensor
Associated traumatic condition that would interfere with the informed consent process or outcome assessments (e.g. traumatic brain injury, pelvic, abdominal, or thoracic injuries)
Any other medical condition that, in the investigator's opinion, would render the protocol procedures dangerous
Female patients who are pregnant
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Allan Aludino
Phone
604-875-4111 ext 61689
Email
allan.aludino@vch.ca
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brian Kwon, MD
Organizational Affiliation
University of British Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vancouver General Hospital
City
Vancouver
State/Province
British Columbia
ZIP/Postal Code
V5Z1M9
Country
Canada
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Allan Aludino
Phone
604-875-4111
Ext
61689
Email
allan.aludino@vch.ca
First Name & Middle Initial & Last Name & Degree
Brian Kwon, MD, PhD
12. IPD Sharing Statement
Learn more about this trial
Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial
We'll reach out to this number within 24 hrs